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The acylation of erythromycin oxime and 9-amino-3-0-cladi-
nosyl-5-0-desosaminyl-6,11,12 - trihydroxy-2,4,6,8,10,12 - hexamethyl-
pentadecane-13-olide (erythromycyl amine) was performed by 
means of dicarboxylic acid chloride esters and the corresponding 
0- and N-acyl derivatives were obtained. A comparison of the 
physical properties and antibiotic activity of these compounds 
with those of corresponding erythromycin esters shows that erythro-
mycin oxime and erythromycyl amine are very similar to erythro-
mycin itself in their chemical and antimicrobial behaviour. 
Acylation of erythromycin with different acid chlorides or acid anhydrides 
yielded a variety of products with a single acyl grouping bound to the hydro-
xyl group of desosaminyl rest (J), The sole exception was when acetanhydride 
was used as an acylating agent to yield erythromycin diacetate1• A large 
number of erythromycin esters with aliphatic mono- and dicarboxylic acids, 
with monoesters of aliphatic dicarboxylic acids, and with aromatic acids 
respectively has been prepared and described1-&. Several of these esters e.g. 
propionate, ethylcarbonate, ethylsuccinate, have been recommended in thera-
peutic praxis owing to their advantages over erythromycin itself. 
In continuation of our experiments on structural modifications in the 
erythromycin molecule10 we have performed a series of acylations of erythro-
mycin oxime and erythromycyl amine with methyl- or ethylesterchlorides of 
succinic resp, adipic acid. By choosing proper reaction conditions it was 
possible to introduce either one or two acyl groups in the molecule. The purity 
of the products was controlled by thin-layer chromatography on Silicagel G 
(Merck) using a methylene chloride-methanol-benzene-formamide (20 : 5 : 5 : 
:0.5) mixture as the developing solvent system. The infrared absorption 
spectra of the prepared acyl derivatives were in good agreement with the 
infrared absorption spectra of erythromycin esters2• 
The formulas, molecular weights and physical properties for the new 
compounds are presented in Table I along with antibiotic activities found 
by the plate bioassay method. The specific rotations of the acyl derivatives 
* Part I. : S, D j o k i c and Z. T am bur as e v, Tetrahedron Letters No. 17 
(1967) 1645. 
** Presented in part at the 2nd Yugoslav Congress for Pure and Applied 
Chemistry, Beograd, June 16, 1966. Abstract of Papers, p . 195. 
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R = X-CO-
differ noticably from group to group (monoacyl-bisacyl-oxime-amine) but not 
significantly within the group. Monoacyl derivatives of erythromycin oxime 
resp. erythromycyl amine show only a slight decrease in their pK'a values 
when compared to the starting compounds. Erythromycin esters on the other 
hand have markedly decreased pK'a values~. The pK'a values of bis · acyl 
derivatives of erythromycin oxime resp. erythromycyl amine are also signi-
ficantly lower. The hydroxyl group of the desosaminyl rest has already been 
established as the site where acylation occurs. It can be suggested that mono-
acylation takes place exclusively at the amino resp . oximino group of erythro-
mycyl amine resp. erythromycin oxime. The second acylation then occurs at 
the hydroxyl group of desosaminyl rest. 
By comparison of the values obtained by the antibiotic assays of the 
compounds described in this paper with those of simple erythromycin esters 
and with starting materials (see Table I and II) the folowing characteristic 
features can be envisaged: the carbethoxy derivatives possess lower activities 
than corresponding carbomethoxy derivatives ; introduction of the second acyl 
group in the molecule does not substantially change the activity of the parent 
compounds; the activities of carbometoxy derivatives do not differ from those 
of starting materials. Erythromycin oxime and erythromycyl amine behave 
very similarly to erythromycin itself in biological tests as well as towards 
acylating agents. 
EXPERIMENTAL 
General Procedure for the Preparation of Monoacyl Derivatives 
of Erythromycin oxime and Erythromycyl amine 
To a solution of erythromycin oxime or erythromycyl amine (6.7 mmoles) in 
dry acetone (100 ml.) dry sodium hydrogen carbonate (2.5 g.) was added. Then a 
solution of one equivalent of the corresponding ester-chloride in dry acetone (25 ml.) 
was added dropwise with stirring over the period of one hour. After stirring for 
one additional hour the reaction mixture was filtered, the filtrate diluted with a 
solution of 2.5 g. of sodium hydrogen carbonate in 130 ml. water and extracted 
with one 100 ml. and two 50 ml. portions of ether. The combined ether extracts 
were dried over anhydrous sodium sulphate filtered and freed from ether in vacuo. 
The crude crystalline product was purified by dissolution in acetone and addition 
of water until persistent turbidity. After standing for three hours crystallization 
sat in. Generally one such crystallization was sufficient to obtain an analytically 
pure product in 70-80°/o yield. 
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TABLE I 
The Physical Properties and Plate Bioassay of 0- and N-acyl Derivativesa 
No. 
II 
III 
IV 
v 
VI 
VII 
VIII 
IX 
I 
Compound 
Erythromycin oxime 
methyl succinate 
Erythromycin oxime 
ethyl succinate 
Erythromycin oxime 
bis-methyl succinate 
Erythromycin oxime 
bis-ethyl succinate 
Erythromycin oxime 
methyl adipate 
Erythromycin oxime 
ethyl adipate 
Erythromycin oxime 
bis-methyl adipate 
Erythromycin oxime 
bis-ethyl adipate 
X Erythromycyl amine 
methyl succinate 
XI 
XII 
XIII 
XIV 
Erythromycyl amine 
ethyl succinate 
Erythromycyl amine 
bis-methyl succinate 
Erythromycyl amine 
bis-ethyl succinate 
Erythromycyl amine 
methyl adipate 
XV Erythromycyl amine 
ethyl adipate 
XVI 
XVII 
Erythromycyl amine 
bis-methyl adipate 
Erythromycyl amine 
bis-ethyl adipate 
Formula 
Mol. 
weight 
C42H14N2016 
863.06 
C43H1sN201r. 
877.09 
C41HsoN2019 
977.16 
C49Hs4N2019 
1005.21 
C44H1sN20rn 
891.12 
C45HsoN201s 
905.14 
C51HssN20rn 
1033.27 
CsaH92N20rn 
1061.32 
C42H10N2015 
848.06 
C43H1sN2015 
863.01 
C41Hs2N201s 
963.17 
C49HsoN201s 
991.23 
C44HsoN2015 
877.13 
C45Hs2N2015 
891.16 
C51H90N201s 
1019.28 
C53H94N201s 
1047.34 
108-112 1 
-125.7 
99-102 -124.3 
173-176 - 109.7 
160-162 - 109.8 
89-94 - 109.3 
82-86 - 110.0 
78-83 - 99.0 
72-76 - 104.7 
114-119 -120.7 
103-105 - 122.4 
95-101 - 108.3 
160-162 -110.1 
102-105 - 115.1 
91-95 - 114.8 
88-90 91.1 
69-71 99.9 
8.31 
8.18 
6.7 
6.61 
8.3 
8.18 
6.57 
6.56 
8.43 
8.39 
6.8 
6.62 
8.4 
I 
Plate 
bioassaye 
u/mg. 
400-450 
250-300 
400-450 
200- 250 
400-450 
350-400 
400-450 
200-2'50 
400-450 
250-300 
450-500 
200-250 
400-450 
8.21 350--400 
6.9 400-450 
6.61 200-250 
•All compounds gave satisfactory C, H and N analyses; h Fischer-Jon es appara t u s; c 2'/• in 
acetone ; <1 660/o dime.thylformamide-water; e British Pharmacopoeia 1963, p . 1102. 
General Procedure for the Preparation of Bis-acyl Derivatives of Erythro-
mycin oxime and Erythromycyl amine 
To a solution of erythromycin oxime or erythromycyl amine (6.7 mmoles) in 
dry acetone (100 ml.) dry sodium hydrogen carbonate (5 g.) was added. Then a 
solution of the corresponding ester-chloride (16.1 mmoles) in dry acetone (50 ml.) 
was added dropwise with stirring over the period of one hour. The stirring was conti-
nued for additional 8 hours whilst heating the reaction mixture .- under reflux. After 
cooling to room temperature and filtration, the clear filtrate was diluted with a 
solution of 5 g. sodium hydrogen carbonate in 250 ml. water and extracted with 
one 100 ml. and two 50 ml. portions of ether. The isolation of the product was 
performed in the same manner as for the mono-acyl derivatives. Yields 70-806/o. 
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analyses, the infrared spectra and pK measurements and to Mrs. Poic for the micro-
biological assay. 
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TABLE Il 
The Physical Properties and Plate Bioassay of Erythromycin, Oxime, Amino 
Compound and of some Erythromycin Esters 
Compound I Ref. I 
m . p . [a.] b° oc 
Plate 
pK bioassay 
u /mg. 
Erythromycin 1 135-140 -73.5 8.6 
11 -78.0 
12 949 
Erythromycin 
oxime 10 184-189 -73.5 520 
Erythromycyl 
amine 10 145-148 -50.0 8.4 480 
Erythromycin 
methyl succinate 6 116-118 -55.0 820 
Erythromycin 
ethyl succinate 6 109-110 -42.5 712 
Erythromycin 
ethyl adipate* 6 113-115 -70.0 no 
• Erythromycin methyl adipate was not prepared. 
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IZVOD 
Studije u redu eritromicina. II. Aciliranje eritromicin oks'ima i 9-amino-3-0-
-kladinozil-5-0-desozaminil-6,11,12-trihidroksi-2,4,6,8,10,12-heksametilpentadekan-
-13-olida sa kloridlma estera .dikarbonskih kiselina 
z. Tamburasev, G. Vazdar i S. Djokic 
Reakcijom eritromicin oksima i 9-amino-3-0-kladinozil-5-0-desozaminil-6,ll-12-
-trihidroksi-2,4,6,8,10,12-heksametilpentadekan-13-olida (eritromicil amina) s kloridima 
metil i etil estera jantarne i adipinske kiseline pripravljeni su odgovarajuci mono-
i bis-acil derivati (II-XVII). Uporedenje fizikalnih svojstava i antibiotskog aktivi-
teta ovih spojeva (Tabela I) s istim vrijednostima odgovarajuCih estera eritromicina 
i njihovih matienih supstancija (Tabela II) pokazuje da se eritromicin oksim i eritro-
micil amin ponasaju vrlo slicno kao eritromicin. 
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